Found 42 matching trials
Clinical Study Using Biologics to Improve Multi OIT Outcomes (COMBINE)
PHASE2Food allergy is a serious public health concern that causes potentially-lif...
Location
University of California Los Angeles (UCLA)
Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE)
PHASE3The purpose of this study is to demonstrate the efficacy and safety of AR10...
Location
Banner University of Arizona Medical Center
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
PHASE2This is a phase II trial that aims at evaluating the safety and tolerabilit...
Location
Boston Children's Hospital
Peanut Oral Induction Tolerance in Peanut's Allergic Teenagers
PHASE2The primary purpose of the protocol is to evaluate the efficacy of a protoc...
Location
CHU Clermont-Ferrand
AR101 Real-World Open-Label Extension Study
PHASE3This study is enrolling participants by invitation only. This is an open-la...
Location
Clinical Research Center of Alabama
Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents
PHASE3To compare the HRQOL of AR101 characterized oral desensitization immunother...
Location
Hospital Universitario Germans Trias i Pujol
Peanut Oral Immunotherapy in Children
PHASE2This is a randomized, double-blind, placebo-controlled, multi-center study ...
Location
University of Arkansas for Medical Sciences: Arkansas Children's Hospital
Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study
PHASE2Peanut allergy is known to cause severe anaphylactic reactions.The goal of ...
Location
University of North Carolina
Nut Allergy Study: Double-blind Challenge and Oral Desensitization
NANut sensitization in skin prick tests is common in areas, including Finland...
Location
Helsinki University Central Hospital, Skin and Allergy Hospital
Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study
PHASE2This application is being submitted as a follow-up to Protocol "Oral Immuno...